Product NDC: | 0002-4771 |
Proprietary Name: | Livalo |
Non Proprietary Name: | pitavastatin calcium |
Active Ingredient(s): | 2 mg/1 & nbsp; pitavastatin calcium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-4771 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022363 |
Marketing Category: | NDA |
Start Marketing Date: | 20100515 |
Package NDC: | 0002-4771-61 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0002-4771-61) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0002-4771-61 |
Proprietary Name | Livalo |
Package Description | 1 BLISTER PACK in 1 CARTON (0002-4771-61) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0002-4771 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pitavastatin calcium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100515 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | PITAVASTATIN CALCIUM |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |